BioNJ Breakfast Briefing:
Innovation in Clinical Trials
Overcoming Challenges in Study Start-Ups
October 5, 2011
7:30 a.m. — 11:00 a.m.
The Conference Center at Robert Wood Johnson – Hamilton
3100 Quakerbridge Road, Mercerville
The convergence of research and development involving biotechnology, pharmaceuticals, diagnostics and medical devices is radically advancing the discovery and development of innovative new medicines and therapies. Well-conceived and conducted clinical trials serve as the linchpin to ensure successful outcomes for companies and patients.
In a state known as the Medicine Chest of the World, BioNJ is proud to represent an industry that is on the cutting edge of far-reaching innovations in human health. In the midst of this rapid change we encourage you to join us as we come together to enhance core competence in all areas of clinical trials through dialogue, collaboration and partnering.
This is event is brought to you by the BioNJ Clinical Trials Advisory Committee.
Featured Speakers and Topics
Jay Backstrom, Corporate VP at Celgene, will be delivering our Keynote Address: Clinical Trials in Oncology – Critical Needs for Innovation.
Dr. Pol Boudes, Chief Medical Officer at Amicus Therapeutics, who is working with rare diseases, will share with us how innovation in clinical trials is a way of life at Amicus Therapeutics.
From Pfizer, we have Craig Lipset, Head of Clinical Innovation, who will be sharing his thoughts and experiences about innovations in clinical trials through the Pfizer lens. He also brings examples of ways Big Pharma can better partner with companies in New Jersey.
Spiro Rombotis, President & CEO of Cyclacel Pharmaceuticals and a BioNJ Board Member, is spearheading the BioNJ Clinical Trials initiative. He will address the positive predictive value of trials and bring us up to date on his work improving the state of clinical trials in New Jersey.
Dr. Marco Taglietti, President & Chief Medical Officer at Forest Research Institute, will help us look at long-term strategies, sharing some of the initiatives at Forest Research Institute that can make New Jersey a much more competitive place to conduct clinical trials
BioNJ Thanks Our Sponsors
